Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tjalling Bosse

Showing results (121-130 of 167) with videos related to

Pageof 17
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 24, 2023
Molecular Classification Predicts Response to Radiotherapy in the Randomized PORTEC-1 and PORTEC-2 Trials for Early-Stage Endometrioid Endometrial CancerNanda Horeweg, Remi A Nout, Ina M Jürgenliemk-Schulz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 11, 2018
Frequent Homologous Recombination Deficiency in High-grade Endometrial CarcinomasMarthe M de Jonge, Aurélie Auguste, Lise M van Wijk, et al.
The Journal of Molecular Diagnostics : JMD|December 7, 2023
MLH1 Promotor Hypermethylation in Colorectal and Endometrial Carcinomas from Patients with Lynch SyndromeNoah C Helderman, Katarina D Andini, Monique E van Leerdam, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 2016
Loss of ARID1A Activates ANXA1, which Serves as a Predictive Biomarker for Trastuzumab ResistanceKatrien Berns, Amir Sonnenblick, Annemiek Gennissen, et al.
The Journal of Pathology|April 1, 2018
Somatic POLE exonuclease domain mutations are early events in sporadic endometrial and colorectal carcinogenesis, determining driver mutational landscape, clonal neoantigen burden and immune responseDaniel Temko, Inge C Van Gool, Emily Rayner, et al.
British Journal of Cancer|January 23, 2023
Prognostic refinement of NSMP high-risk endometrial cancers using oestrogen receptor immunohistochemistryLisa Vermij, Jan J Jobsen, Alicia León-Castillo, et al.
Cancer|April 1, 2021
Evaluation of treatment effects in patients with endometrial cancer and POLE mutations: An individual patient data meta-analysisJessica N McAlpine, Derek S Chiu, Remi A Nout, et al.
Familial Cancer|May 5, 2025
Evaluation of BRCA1/2 testing rates in epithelial ovarian cancer patients: lessons learned from real-world clinical dataLieke Lanjouw, Claire J H Kramer, Arja Ter Elst, et al.
The Journal of Molecular Diagnostics : JMD|June 25, 2018
Validation and Implementation of BRCA1/2 Variant Screening in Ovarian Tumor TissueMarthe M de Jonge, Dina Ruano, Ronald van Eijk, et al.
Cancer Immunology Research|March 16, 2019
A Transcriptionally Distinct CXCL13<sup>+</sup>CD103<sup>+</sup>CD8<sup>+</sup> T-cell Population Is Associated with B-cell Recruitment and Neoantigen Load in Human CancerHagma H Workel, Joyce M Lubbers, Roland Arnold, et al.
Pageof 17

Showing results (121-130 of 167) with videos related to

Sort By:
Pageof 17
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 24, 2023
Molecular Classification Predicts Response to Radiotherapy in the Randomized PORTEC-1 and PORTEC-2 Trials for Early-Stage Endometrioid Endometrial CancerNanda Horeweg, Remi A Nout, Ina M Jürgenliemk-Schulz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 11, 2018
Frequent Homologous Recombination Deficiency in High-grade Endometrial CarcinomasMarthe M de Jonge, Aurélie Auguste, Lise M van Wijk, et al.
The Journal of Molecular Diagnostics : JMD|December 7, 2023
MLH1 Promotor Hypermethylation in Colorectal and Endometrial Carcinomas from Patients with Lynch SyndromeNoah C Helderman, Katarina D Andini, Monique E van Leerdam, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 2016
Loss of ARID1A Activates ANXA1, which Serves as a Predictive Biomarker for Trastuzumab ResistanceKatrien Berns, Amir Sonnenblick, Annemiek Gennissen, et al.
The Journal of Pathology|April 1, 2018
Somatic POLE exonuclease domain mutations are early events in sporadic endometrial and colorectal carcinogenesis, determining driver mutational landscape, clonal neoantigen burden and immune responseDaniel Temko, Inge C Van Gool, Emily Rayner, et al.
British Journal of Cancer|January 23, 2023
Prognostic refinement of NSMP high-risk endometrial cancers using oestrogen receptor immunohistochemistryLisa Vermij, Jan J Jobsen, Alicia León-Castillo, et al.
Cancer|April 1, 2021
Evaluation of treatment effects in patients with endometrial cancer and POLE mutations: An individual patient data meta-analysisJessica N McAlpine, Derek S Chiu, Remi A Nout, et al.
Familial Cancer|May 5, 2025
Evaluation of BRCA1/2 testing rates in epithelial ovarian cancer patients: lessons learned from real-world clinical dataLieke Lanjouw, Claire J H Kramer, Arja Ter Elst, et al.
The Journal of Molecular Diagnostics : JMD|June 25, 2018
Validation and Implementation of BRCA1/2 Variant Screening in Ovarian Tumor TissueMarthe M de Jonge, Dina Ruano, Ronald van Eijk, et al.
Cancer Immunology Research|March 16, 2019
A Transcriptionally Distinct CXCL13<sup>+</sup>CD103<sup>+</sup>CD8<sup>+</sup> T-cell Population Is Associated with B-cell Recruitment and Neoantigen Load in Human CancerHagma H Workel, Joyce M Lubbers, Roland Arnold, et al.
Pageof 17